Clinical performance of a highly porous beta-TCP as the grafting material for maxillary sinus augmentation.

Abstract

BACKGROUND:

Beta-tricalcium phosphate (β-TCP) is a synthetic bone substitute having high porosity and fast resorption. This retrospective study aimed at evaluating the effectiveness of an highly macroporous β-TCP for maxillary sinus floor augmentation.

METHODS:

Twenty-seven consecutive patients (17 woman/10 men, mean age: 59.7 years) in 2 clinics underwent maxillary sinus augmentation by lateral approach using β-TCP as grafting material. Implant survival, prosthesis success, periimplant bone loss, oral hygiene level, soft tissue condition, complication occurrence, and patient satisfaction were assessed.

RESULTS:

Thirty-one sinuses were successfully augmented. Sixty implants were placed. No sinus membrane perforations occurred. The mean follow-up after grafting was 39.3 ± 8.7 months (range, 22-52 months), and it was 30.5 ± 8.1 months (range, 15-43 months) after implant loading. No implants were lost. After 1 year of loading, marginal bone loss averaged -0.88 ± 0.46 mm (n = 54 implants). Mean full-mouth plaque and bleeding scores were 11.5% ± 4.8% and 3.5% ± 2.8%, respectively. No biological or mechanical complications were recorded. Patient satisfaction was very high.

CONCLUSION:

Despite limited sample size and follow-up duration, highly macroporous β-TCP proved a valuable bone substitute for sinus augmentation, even when used alone.

• Authors: Raphael Bettach, Bernard Guillaume, Silvio Taschieri, Massimo Del Fabbro
• Journal: Implant dentistry (Implant Dent) Vol. 23 Issue 3 Pg. 357-64 (Jun 2014) ISSN: 1538-2982 [Electronic] United States
• PMID: 24819814 (Publication Type: Clinical Trial, Journal Article)

Chemical References

• Biocompatible Materials
• Bone Substitutes
• Calcium Phosphates
• beta-tricalcium phosphate

Topics

• Biocompatible Materials (therapeutic use)
• Bone Substitutes (therapeutic use)
• Calcium Phosphates (therapeutic use)
• Dental Prosthesis Retention
• Female
• Humans
• Male
• Middle Aged
• Retrospective Studies
• Sinus Floor Augmentation (adverse effects, methods)
• Treatment Outcome